Adaptive Testing Technologies

What Adaptive Testing Technologies does

Adaptive Testing Technologies, Inc. (ATT) is a Chicago-based private health technology company founded in 2011 that develops computerized adaptive testing (CAT) software for mental and behavioral health assessment. Its core products — CAT-MH® for adults and K-CAT® for children ages 7-17 — use multi-dimensional item response theory (MIRT) to adaptively select items from calibrated banks of approximately 1,500 and 2,120 items respectively, producing severity scores for depression, anxiety, suicidality, PTSD, substance use disorder, psychosis, mania/hypomania, ADHD, and social determinants of health in roughly 2 minutes per module. Both suites are validated against structured clinical diagnostic interviews (SCID-DSM-5) and are deployed on a HIPAA-secure AWS cloud with HITRUST certification, accessible via API, and integrated with Epic EHR (deployed at the University of Chicago). The company also offers the CASSY tool and the pCAT-COG prototype for cognitive assessment.

ATT generates revenue through subscription-based enterprise licensing to institutional buyers — hospitals, emergency departments, insurers, managed care organizations, university counseling systems, state agencies, and first-responder departments — with custom multi-year contracts sold through direct enterprise sales and, since July 2025, through a distribution partnership with Pearson Assessments on the Q-global® platform. The go-to-market is content- and research-led (peer-reviewed publications, webinars, LinkedIn, newsletter), targeting clinical administrators and public health officials rather than end consumers, with sales conducted exclusively through licensed healthcare professionals and authorized administrators. Strategic priorities visible in 2025 include expanding into cognitive assessment (pCAT-COG), embedding in Epic-based health systems, broadening into first-responder and state-government verticals, and scaling distribution through Pearson.

Name

Adaptive Testing Technologies

Legal name

Adaptive Testing Technologies, Inc.

Website

https://adaptivetestingtechnologies.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

Adaptive Testing Technologies develops computerized adaptive tests for mental health (CAT-MH® for adults, K-CAT® for children) and cognitive function, selling subscription enterprise software to hospitals, insurers, government agencies, universities, and first-responder organizations via direct sales and the Pearson Q-global® platform.

Ownership category

akta.pro rank

Product category

Mental Health Assessment Software

NAICS

Other Computer Related Services (541519)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Computerized Adaptive Testing (CAT) & Psychometric Analytics Platforms (EDAFADAD)

akta.pro secondary industry

Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software (HLACANAD)

Keywords

• Computerized adaptive testing
• Mental health assessment
• Behavioral health screening
• Clinical decision support
• Patient-reported outcomes

Headquarters

HQ city

Chicago

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. SaaS / Software Licensing for Mental Health Assessments: Adaptive Testing Technologies generates revenue by providing computerized adaptive mental health assessment software (CAT-MH® and K-CAT®) to licensed healthcare professionals, hospitals, insurance companies, managed care organizations, and other authorized administrators. The company offers its tools via a cloud-based platform with API integration capabilities. Based on the enterprise sales motion (Request a Demo, licensed administrator requirement), the revenue model is subscription-based software licensing to institutional buyers.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

Adaptive Testing Technologies designs, validates, and licenses computerized adaptive testing software for mental and behavioral health assessment. Its CAT-MH® suite screens adults for nine-plus conditions in roughly two minutes per module using MIRT-based adaptive item selection, and its K-CAT® product provides an equivalent children's battery for ages 7–17. The tools are sold to licensed clinicians, hospitals, insurers, managed care organizations, government agencies, universities, and law enforcement via a HIPAA-secure AWS cloud platform with Epic EHR API integration.

Product overview

Adaptive Testing Technologies offers a platform of computerized adaptive testing products for mental and behavioral health assessment. The core offerings are the CAT-MH® suite for adults and K-CAT® for children ages 7-17, both utilizing multi-dimensional item response theory (MIRT) to adaptively select items from large banks (1,500+ items for adults, 2,120 for children). The CAT-MH® and K-CAT® platforms can administer individual modules targeting specific conditions (depression, anxiety, substance use disorder, suicidality, PTSD, etc.) or full batteries. Additionally, the company is developing the pCAT-COG for cognitive assessment and offers the CASSY tool. All assessments are cloud-based, HIPAA-secure, and can be integrated via API into electronic health records.

Differentiator

Problem solved

Functional benefit

Brands

• CAT-MH®: Computerized Adaptive Tests for Mental Health - a suite of measures validated for depression, anxiety, mania/hypomania, substance use disorder, psychosis, PTSD, social determinants of health, adult ADHD, and suicidality in adults.
• K-CAT®
• CASSY

Products and services

• CAT-MH® (Computerized Adaptive Test for Mental Health) A suite of computerized adaptive mental health assessments for adults, validated against structured clinical diagnostic interviews (SCID-DSM-5). Using multi-dimensional item response theory (MIRT), the platform adaptively selects items from a bank of approximately 1,500 items and screens for depression, anxiety, mania/hypomania, substance use disorder, psychosis, PTSD, social determinants of health, adult ADHD, and suicidality in approximately 2 minutes per module. Sold to licensed clinicians, hospitals, insurers, managed care, and government entities via cloud delivery and EHR integration. Available in English, Spanish, and Chinese with selectable audio for literacy support.
• K-CAT® (Kiddie-Computerized Adaptive Test) A children's version of CAT-MH® validated for youth ages 7 to 17, with both self-rated and parent/caregiver-rated modules covering depression, anxiety, mania/hypomania, ADHD, substance use disorder, conduct disorder, ODD, PTSD, and suicidality. Uses a separate item bank of 2,120 items and is administered in approximately 2 minutes per module. Available in English and Spanish with selectable audio. Sold to pediatric EDs, child welfare agencies, university counseling systems, and community mental health providers.
• CASSY An additional assessment tool offered by Adaptive Testing Technologies alongside CAT-MH® and K-CAT® to support mental health screening and measurement-based care.
• pCAT-COG (prototype Computerized Adaptive Test for Cognitive Function) A prototype computerized adaptive cognitive assessment tool using multi-dimensional item response theory for early detection of cognitive decline. Evaluates global cognitive function and five domains (episodic memory, semantic memory/language, working memory, executive function/flexible thinking, processing speed) using 57 items calibrated with a bifactor MIRT model. Differentiates individuals with mild cognitive impairment (MCI) from those without cognitive impairment using only 11 items.

Quantifiable outcome

• 2.5-fold increase in identification of moderate-to-severe depression compared to visit-based screening (PORTAL-Depression Study)
• +6 more outcomes

Named customers6 records

Segments6 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability4 records

Feature5 records

Partnerships

Six partnerships are on record, tiered core.

• Pearson AssessmentscoreChannel Partner/ Reseller/ Distributor · 10 July 2025Pearson is partnering with Adaptive Testing Technologies to bring the CAT-MH® and K-CAT® mental and behavioral health assessments to the Q-global® platform. This partnership expands distribution of ATT's assessment tools through Pearson's established global assessment platform, targeting institutional buyers in education, healthcare, and corporate wellness markets.
• Epic Systems (EHR Integration)coreTechnology or IntegrationAdaptive Testing Technologies has fully integrated the CAT-MH® into the Epic EHR at the University of Chicago and developed clinical workflows designed around the integration. This enables seamless inclusion of CAT-MH® assessments within the Epic clinical environment, with results exportable and viewable directly within the EHR.
• SAMHSA / RTI InternationalcoreStrategic or Co-development PartnerThe CAT-MH® is being used as the 1st-stage diagnostic screener in the largest national survey of mental health and substance use disorders in history, conducted by SAMHSA (Substance Abuse and Mental Health Services Administration) and implemented by RTI International.
• University of ChicagocoreStrategic or Co-development PartnerUniversity of Chicago conducted a CAT-MH® study of 1,000 patients in the emergency department, screened for depression using CAD-MDD and CAT-DI. The university also completed full Epic EHR integration of CAT-MH® and is home to company founder Robert Gibbons and other key collaborators.
• NYU Grossman School of MedicinecoreStrategic or Co-development PartnerResearchers at NYU Grossman School of Medicine conducted a study of K-CAT® effectiveness in two high-volume pediatric emergency departments, demonstrating that K-CAT® identified significantly more youth at risk for suicide than standard C-SSRS screening.
• Virginia Commonwealth University (VCU)coreStrategic or Co-development PartnerResearchers at VCU, including Dr. Paige Cervantes (Department of Psychiatry), led the pilot study 'Perspectives on the K-CAT-SS for Autistic Youth' evaluating K-CAT® for suicide risk assessment in autistic youth aged 7-17.

Scale indicators12 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Pearson Clinical Assessments: Pearson operates the Q-global® digital assessment platform, which hosts a broad portfolio of standardized clinical and educational assessments. Pearson is both a distribution partner and the most significant incumbent in the digital psychometric assessment space, with overlapping clinician customers and a competing product roadmap.
• Quartet Health: Quartet Health is a behavioral health platform that coordinates mental health referrals and measurement-based care between primary care and behavioral health providers. It competes for the same institutional buyer (payers, health systems) seeking population-level mental health quality and outcomes improvement.
• Lyra Health: Lyra Health is a mental health benefits platform offering therapy, coaching, and assessment services to enterprise employers and payers. While primarily a care-delivery platform, it overlaps with ATT in serving enterprise buyers seeking validated mental health measurement and outcomes data.

Direct peers

• Multi-Health Systems (MHS): MHS publishes a wide range of computerized psychological and behavioral assessments distributed to clinicians, schools, and researchers. Like ATT, it sells evidence-based assessment instruments with a digital delivery model and shares overlap in clinical and research customer segments.
• Psychological Assessment Resources (PAR): PAR develops, publishes, and distributes standardized psychological assessment instruments used by clinicians, schools, and researchers. Its product portfolio and digital delivery overlap directly with ATT's CAT-MH® and K-CAT®, particularly in mental health screening and outcome measurement.
• Creyos Health: Creyos (formerly Cambridge Brain Sciences) provides computerized cognitive and behavioral health assessments delivered via web-based platforms to clinicians, researchers, and direct-to-consumer channels. It is one of the closest direct competitors in computerized adaptive-style assessment for mental and cognitive health.
• CNS Vital Signs: CNS Vital Signs offers a computerized neurocognitive assessment battery used by clinicians and researchers to evaluate cognitive function and mental health symptoms. It competes in the same computerized clinical-assessment category as ATT, particularly in primary care, behavioral health, and research settings.
• Cambridge Cognition: Cambridge Cognition develops digital cognitive assessment tools (including CANTAB) for clinical trials, healthcare providers, and research institutions. Its focus on computerized assessment validated against clinical endpoints is highly comparable to ATT's psychometric validation approach.

Emerging players

• BrainCheck: BrainCheck provides rapid computerized cognitive assessment tools targeting concussion, dementia, and general cognitive health. It overlaps with ATT's emerging pCAT-COG cognitive assessment line, although it is earlier-stage and focused primarily on clinical neurology and primary care.

Others

• Mindstrong (defunct asset / Pear Therapeutics-adjacent): While Mindstrong itself shut down, Pear Therapeutics pioneered prescription digital therapeutics (PDTs) for mental and behavioral health and represents the broader category of clinically validated, FDA-cleared software used in mental health treatment. It is a thematic peer signaling both the opportunity and difficulty of building a clinically validated mental-health software business.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/adaptive-testing-technologies

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles20 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Adaptive Testing Technologies